Tivic Health (TIVC) announced it has completed all study visits in the Optimization Study for its non-invasive cervical vagus nerve stimulation device. The study, conducted by The Feinstein Institute of Bioelectronic Medicine, aimed to identify device parameters that optimally influence autonomic nervous system function. Tivic expects to release study results later this year and apply the findings to an upcoming Phase I clinical trial.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TIVC: